Expression of α-SMA in astrocytes has been found to be increased in certain types of disorders affecting the CNS such as multiple sclerosis and Alzheimer’s disease [39, 40]. This evidence concerns the gene ACTA1 and early-onset autosomal dominant Alzheimer disease.